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Short-term results of a randomized trial examining
timing of carotid endarterectomy in patients with
severe asymptomatic unilateral carotid stenosis
undergoing coronary artery bypass grafting
Giulio Illuminati, MD,a Jean-Baptiste Ricco, MD,b Francesco Caliò, MD,a
Maria Antonietta Pacilè, MD,a Fabio Miraldi, MD,c Giacomo Frati, MD,c Francesco Macrina, MD,c and
Michele Toscano, MD,c Rome, Italy; and Poitiers, France
Objective: This study evaluated the timing of carotid endarterectomy (CEA) in the prevention of stroke in patients with
asymptomatic carotid stenosis >70% receiving a coronary artery bypass graft (CABG).
Methods: From January 2004 to December 2009, 185 patients with unilateral asymptomatic carotid artery stenosis>70%,
candidates for CABG, were randomized into two groups. In group A, 94 patients received a CABG with previous or
simultaneous CEA. In group B, 91 patients underwent CABG, followed by CEA. All patients underwent preoperative
helical computed tomography scans, excluding significant atheroma of the ascending aorta or aortic arch. Baseline
characteristics of the patients, type of coronary artery lesion, and preoperative myocardial function were comparable in
the two groups. In group A, all patients underwent CEA under general anesthesia with the systematic use of a carotid
shunt, and 79 patients had a combined procedure and 15 underwent CEA a few days before CABG. In group B, all
patients underwent CEA, 1 to 3 months after CABG, also under general anesthesia and with systematic carotid shunting.
Results:Two patients (one in each group) died of cardiac failure in the postoperative period. Operative mortality was 1.0%
in group A and 1.1% in group B (P  .98). No strokes occurred in group A vs seven ipsilateral ischemic strokes in group
B, including three immediate postoperative strokes and four late strokes, at 39, 50, 58, and 66 days, after CABG. These
late strokes occurred in patients for whom CEA was further delayed due to an incomplete sternal wound healing or
because of completion of a cardiac rehabilitation program. The 90-day stroke and death rate was 1.0% (one of 94) in
group A and 8.8% (eight of 91) in group B (odds ratio [OR], 0.11; 95% confidence interval [CI], 0.01-0.91; P  .02).
Logistic regression analysis showed that only delayed CEA (OR, 14.2; 95% CI, 1.32-152.0; P  .03) and duration of
cardiopulmonary bypass (OR, 1.06; 95% CI, 1.02-1.11; P  .004) reliably predicted stroke or death at 90 days.
Conclusions: This study suggests that previous or simultaneous CEA in patients with unilateral severe asymptomatic
carotid stenosis undergoing CABG could prevent stroke better than delayed CEA, without increasing the overall surgical
risk. ( J Vasc Surg 2011;54:993-9.)
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TPatients who are candidates for coronary artery bypass
grafting (CABG) have a 3% to 10% incidence of associated
significant carotid artery stenosis. In this setting, patients
presenting with a unilateral carotid artery stenosis of 80% to
99% carry an increased risk of stroke of about 4%.1-7 Even if
the first report of combined carotid endarterectomy (CEA)
and CABG dates from 1972,8 we still lack evidence on
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doi:10.1016/j.jvs.2011.03.284hether prophylactic CEA before or combined with CABG
ignificantly lowers the stroke rate.
Contrary to reports showing the efficacy and safety of
rophylactic CEA before CABG,9-14 some authors have
uestioned the validity of preventive carotid artery revascu-
arization, suggesting that CEA in patients with asymptom-
tic carotid stenosis does not significantly lower the rate of
schemic stroke after CABG.15-18 These conflicting results
re probably related to the heterogeneity of the patients
nrolled, especially the degree of carotid stenosis, and to
he details of the coronary revascularizations performed.
his randomized study tested the hypothesis that in pa-
ients with asymptomatic carotid artery stenosis 70% un-
ergoing CABG, CEA before or combined with CABG
ould prevent stroke better than delayed CEA, without
ncreasing the overall risk of surgery.
ATERIALS AND METHODS
Study design. This randomized study was conducted
t one academic surgical center and one affiliated hospital.
he Institutional Review Board of the University of Rome
pproved the trial protocol, and all patients provided writ-
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October 2011994 Illuminati et alten informed consent. Random assignment of patients to
the treatment groups was done independently of participat-
ing centers in a one-to-one ratio. The randomization se-
quence was generated by a computer program and supplied
to centers using sealed envelopes generated in blocks of six.
Selection of patients. All of the patients enrolled in
the studymet the criteria for elective CABG for triple-vessel
or left main trunk symptomatic coronary artery disease
(CAD) associated with unilateral, asymptomatic carotid
stenosis 70% on preoperative color duplex ultrasound
scans, and with the absence of significant atherosclerotic
disease of the ascending aorta, aortic arch, and supra-
aortic trunks at helical computed tomography (CT) scan.
The specific criteria to define a stenosis 70% were a
peak systolic velocity 250 cm/s at duplex ultrasound
imaging, confirmed at CT scan, according toNorthAmerican
Symptomatic Carotid Endarterectomy (NASCET) method-
ology.19
Because many strokes in conjunction with on-pump
CABG are probably caused by atheromatous embolization
from the ascending aorta, identifying and excluding pa-
tients with atheromatous disease of the ascending aorta,
aortic arch, and supra-aortic trunks by CT scanning was
considered for all patients in this study to focus strictly on
Fig. Flow chart of the study also shows the inclusion and
carotid endarterectomy; SAT, supra-aortic trunks.the potential risk of associated carotid disease. Helical CT acan was also systematically performed to confirm carotid
rtery stenosis and indication for CEA as well as to assess
he status of intracranial circulation. Significant atheroscle-
otic disease of the ascending aorta, aortic arch, and supra-
ortic trunks was defined as any thrombus-lined lesion from
he aortic valve to the ostium of the left common carotid
rtery, regardless of its diameter, extension, or calcium
ontent.
The study excluded patients undergoing urgent
ABG, defined as any revascularization performed outside
ormal operating hours or displacing other patients from
he surgical schedule. Also excluded were patients under-
oing CABG with intra-aortic balloon pump, off-pump
ABG, or other associated cardiac operations such as val-
uloplasty or valvular replacement.
After determination of eligibility for the trial (Fig),
atients were randomly assigned to undergo prophylactic
EA before CABG or CEA combined with CABG (group
), the timing of CEA being at the surgeon’s preference, or
ABG first, followed by CEA 3 months later (group B).
o patient was excluded from the study due to surgeon’s
reference or patient refusal.
All patients received oral statin treatment with atorva-
tatin (20 mg/d) for at least a week before their operation,
sion criteria.CABG,Coronary artery bypass graft;CEA,exclund all patients received low-molecular-weight heparin in
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Volume 54, Number 4 Illuminati et al 995the perioperative period and aspirin (100mg/d) beginning
1 week after CABG.
Study end points. The primary end point of the study
was the overall stroke/mortality rate in the 90 days after
CEA or CABG. The trial was specifically designed to extend
this primary end point beyond the classic 30 postoperative
days to have a longer period in which to include the results
of delayed CEA in group B. An ischemic stroke was defined
as any neurologic damage lasting24 hours occurring after
CEA or 90 days after CABG. Morbidity was recorded,
including the occurrence of cervical hematoma after CEA.
Follow-up and statistical analysis. All patients were
monitored for 90 days after CABG. The study was designed
with a power of 80% to detect differences in primary out-
come in 90 patients per group, with a two-sided  risk of
0.05, on the basis of a 5% difference in the incidence of
postoperative stroke after CABG alone compared with
patients receiving CEA first or combined with CABG.
Continuous data were compared using the t test, and
proportions were compared using 2 and the Fischer exact
test where appropriate.
A discriminant analysis was performed with “stroke and
death at 90 days” as the discriminant variable. After this
analysis, predictor variables significantly associated with a
postoperative stroke or with a value of P .10 were entered
in a logistic regressionmodel with calculation of the P value
and the odds ratio (OR) with 95% confidence intervals
(CIs). Differences between the two groups were considered
statistically significant at values of P  .05. All calculations
were done using SPSS 19 software (SPSS Inc, Chicago, Ill).
RESULTS
From January 2004 to December 2009, the study
enrolled 184 of 388 initially eligible patients (Fig). No
patient was excluded due to surgeon’s preference or patient
refusal. During the same period, 3294 CABG were per-
formed. Among the 185 enrolled patients, 94 were ran-
domized to undergo CEA a few days before CABG or CEA
combined with CABG (group A), and 91 underwent CEA
1 to 3 months after CABG (group B). No significant
differences between the two groups were observed for
demographic variables or risk factors (Table I), and indica-
tions for CABG were also evenly distributed. In group A,
15 patients (16%) underwent CEA with a median time of 6
days before CABG (range, 5-11 days), whereas 79 patients
(84%) underwent CEA combined with CABG. All of the
patients in this group underwent CEA under general anes-
thesia and with the systematic use of a carotid shunt. The
surgical technique consisted of a standard CEA via a longi-
tudinal arteriotomy closed on a Dacron patch (Intervascu-
lar, La Ciotat, France). Cervical drainage was routinely left
in place and removed 1 to 3 days after surgery.
The patients in group B underwent CEA under general
anesthesia, with systematic carotid shunting, and the same
surgical technique as patients in group A. The details of
CABG, including left ventricular ejection fraction as mea-
sured by transthoracic echocardiogram, mean duration of
cardiopulmonary bypass (CPB), mean number of coronary irtery bypass grafts, and rate of redo CABG in both groups
re reported in Table I. Patients in group A had a signifi-
antly shorter mean duration of CPB than those in group B,
espectively 85  16 vs 90  15 minutes (P  .03).
ostoperative atrial fibrillation occurred in 26 patients
28%) in group A and in 23 patients (26%) in group B,
hich had resolved in all but two patients in group A and in
hree patients in group B by the time of hospital discharge.
Combined stroke and mortality rate. Postoperative
ortality was 1.0% in group A and 1.1% in group B (P 
98). The combined 90-day stroke and death rate was 1.0%
one of 94) in group A [CI 95%] and 9.0% (eight of 91) in
roup B (P  .02), OR, 0.11 [95% CI, 0.01-0.91]. Two
atients (one in each group) died of heart failure in the
ostoperative period. As reported in Table II, the rate of
able I. Patient characteristics
Group A Group B
haracteristics (n  94) (n  91) P
ge, years 67  7 66  6 .37
en 59 (62.8) 61 (67.0) .54
ypertension 76 (80.9) 71 (78.0) .63
mokers 45 (47.9) 47 (51.6) .60
yperlipidemia 26 (27.7) 30 (33.0) .43
iabetes 25 (26.6) 21 (23.1) .58
OPD 36 (38.3) 38 (41.8) .63
ower limb occlusive disease 13 (13.8) 11 (12.1) .72
hronic renal insufficiencyb 3 (3.2) 4 (4.4) .66
I  24 hours 24 (25.5) 19 (20.9) .45
table angina 33 (35.1) 36 (39.6)
nstable angina 54 (57.4) 47 (52.6) .72
ffort dyspnea (%) 7 (7.4) 8 (8.8)
ean preoperative LVEF 35.6  5.7 39.2  6.0 .21
ean duration of CPB,
minutes
85.0  16.9 90.3  15.8 .03
rafts per patient 3.05  0.37 3.02  0.34 .42
atients with redo CABG 5 4 .77
ABG,Coronary artery bypass grafting;COPD, chronic obstructive pulmo-
ary disease; CPB, cardiopulmonary bypass; LVEF, left ventricular ejection
raction; MI, myocardial infarction.
Continuous data are presented as mean  standard deviation; categoric
ata as number (%).
Defined as serum creatinine level 125 mmol/L.
able II. Postoperative stroke, death, and cervical
ematoma by univariate analysis
Group A Group B
n  94 n  91
ariable No. (%) No. (%) P
perative mortality 1 (1.0) 1 (1.1) .98
ll strokesa 0 (0.0) 7 (7.7) .008
0-day combined stroke/deathb 1 (1.0) 8 (8.8) .018
ost-op cervical hematoma 2 (2.1) 0 (0.0) .16
Relative risk, 0.92 (95% confidence interval, 0.87-0.97); number needed to
reat to avoid a stroke  13.
Relative risk, 0.92 (95% confidence interval, 0.86-0.98), number needed to
reat  12.9.psilateral ischemic stroke was 0% in group A and 7.7% (n
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October 2011996 Illuminati et al7) in group B (P  .008) [relative risk, 0.92, with 95% CI,
0.87-0.97; number treated to avoid stroke  13].
In group B, all the strokes were ischemic and ipsilateral.
Three occurred during CABG and four at 39, 50, 58 and
66 days, respectively, after CABG. In these four patients,
CEA had been delayed while waiting for a sternal dehis-
cence to heal in one patient and for completion of a
prolonged cardiovascular rehabilitation in the other three
patients. None of the postoperative strokes occurred in
patients who sustained postoperative atrial fibrillation, and
no stroke, either hemorrhagic or contralateral to the ca-
rotid stenosis, was observed in the entire study cohort. The
main features of the observed strokes are detailed in Table
III. Two patients (2.1%) in group A presented with a
postoperative cervical hematoma, but no postoperative he-
matoma was observed in group B (P  .16; Table II).
The overall mortality and stroke rates for all patients
with CABG performed during the study period, but out-
side the trial, were 2.3% and 1.1%, respectively. Among the
36 patients with unilateral carotid stenosis, but excluded
from the trial because of arch atheroma, three (8.3%)
sustained a postoperative stroke (two ipsilateral and one
contralateral).
Discriminant and logistic regression analysis.
Discriminant analysis was performed with “stroke and
death at 90 days” as the discriminant variable and left
ventricular ejection fraction (LVEF), duration of CPB,
Table III. Group B: Details concerning the 90-day stroke
Pt. Timing
CPB duration
(minutes)
1 Post-op 125
2 Post-op 70
3 Post-op 90
4 39 days 80
5 50 days 110
6 58 days 60
7 66 days 135
CPB, Cardiopulmonary bypass.
aAll strokes were ipsilateral hemispheric strokes.
Table IV. Logistic regression analysis with variables in the
Step Ia   SEb Waldc
CPB, minutes 0.064  0.022 8.225
LVEF 0.005  0.073 .004
Groups 2.654  1.210 4.812
MI 1.796  0.965 3.464
Constant 11.817  4.380 7.280
CI, Confidence interval; CPB, cardiopulmonary bypass; LVEF, left ventricula
aVariables entered on step I are CPB, LVEF, groups, and MI.
bCoefficients and the SE for each predictor variable in the model. The ne
increasing LVEF.
cWald statistic and associated P values indicate how useful each predictor va
indicate that an increase in the value of the predictor variable is associated wi
magnitude of the association (SPSS 19 software; SPSS Inc, Chicago, Ill).previous myocardial infarction (MI), and group as predic- Cor variables. Univariate analysis of variation of 185 cases
evealed that the patients who died or sustained a stroke,
ompared with patients with no complications, differed
ignificantly on three of these four predictor variables: MI,
uration of CPB, and group. A single discriminant function
as calculated and was significantly different for patients
ith or without stroke (2 33.0, df 4, P .005). The
orrelation between predictor variables and the discrimi-
ant function suggested that duration of CPB and group
ere the best predictors of postoperative stroke and death.
verall, the discriminant function successfully predicted
utcome for 85.9% of the 185 patients.
A logistic regression analysis was performed with the
ame discriminant and predictor variables. A total of 185
ases were analyzed and the full model significantly pre-
icted “stroke or death” status (omnibus 2 26.9, df 4,
 .005). Overall, 95.7% of predictions were accurate.
able IV gives coefficients and the Wald statistics for each
f the predictor variables. This shows that only duration of
PB (OR, 1.06; 95%CI, 1.02-1.11; P .004) and delayed
EA (OR, 14.2; 95% CI, 1.33-152.0; P  .03) reliably
redicted postoperative death or stroke at 90 days.
ISCUSSION
This study shows that CEA before CABG or combined
ith CABG can prevent stroke better in patients with an
symptomatic carotid artery stenosis 70% undergoing
Severity Outcome Time
iparesis Recovery 2 months
noparesis Recovery 2 weeks
iparesis Persistent 4 weeks
asia, hemiparesis Partial recovery 6 months
asia, monoparesis Partial recovery 3 months
iparesis Partial recovery 2 months
noparesis Recovery 3 months
ation
df P OR (95% CI)
1 .004 1.067 (1.021–1.115)
1 .948 0.995 (0.862-1.149)
1 .028 14.205 (1.327-152.099)
1 .063 6.025 (0.909-39.934)
1 .007 .000
tion fraction;MI,myocardial infarction; OR, odds ratio; SE, standard error.
coefficient for LVEF indicates the odds of stroke and death decline with
is. In this case, only CPB and groups are significant. Odds ratio less than 1
crease in the odds of the event (stroke and death). The 95% CI indicate thesa
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Volume 54, Number 4 Illuminati et al 997complication rate of surgery. This finding concerns only a
selected group of patients undergoing nonurgent CABG
without off-pump revascularization or associated cardiac
procedures. These selection criteria were decided so that we
could compare two homogeneous groups of patients. In
addition, the study period was extended to 90 days after
CABG so that any neurologic or life-threatening events
occurring between 30 and 90 days after CABG or delayed
CEA could be considered. The absence of any contralateral
stroke in this series is probably due to the exclusion of
patients with arch atheroma.
Our results are in agreement with other series reporting
that CEA, combined with CABG or preceding CABG, can
be performed safely.9-14 Two population-based reports
gave contradictory results; however, Brown et al20 calcu-
lated a combined stroke/mortality rate of 17.7% for 226
simultaneous CEA and CABG procedures performed in 10
states in a 1-year period (1995 to 1996), and Timaran et
al21 recently found a stroke/mortality rate of 8.6% for
combined procedures in a United States national survey
extending from 2000 to 2004.
Other studies have questioned the validity of this ap-
proach, arguing that the risk of postoperative stroke related
to asymptomatic carotid stenosis was minimal compared
with the overall neurologic risk of CABG. They suggest
that CEA does not significantly lower the stroke rate of
cardiac surgery.15-18,22 All of these studies, however, con-
sisted of meta-analyses of small or retrospective series, with
all their limitations.11 Naylor et al,15 in a comprehensive
review of 8972 patients undergoing (1) synchronous revas-
cularization, (2) staged CEA followed by CABG, or (3)
reversed-staged CABG, followed by CEA, reported a risk of
death or stroke after each procedure of 8.7%, 6.1%, and
7.3%, respectively. The differences did not reach statistical
significance. Furthermore, the authors observed that there
was significant variability in reporting events between stud-
ies with consequent heterogeneity among the compared
groups.15
After this meta-analysis, two recent reports found no
significant increase in the incidence of stroke during CABG
or other cardiac operations in patients who presented with
asymptomatic carotid stenosis and did not receive prophy-
lactic or combined CEA.16,17 However, these studies in-
cluded100 patients with a follow-up that did not exceed
30 days in one of the studies17 and with a significant
number of patients with off-pump CABG or other associ-
ated cardiac operations. In addition, neither of these two
studies actually addressed the issue of management of the
carotid stenosis that was not operated on.
One additional retrospective study23 commented spe-
cifically on the risk of stroke in patients with bilateral
carotid stenosis who undergo CABG in the presence of an
unoperated-on contralateral carotid stenosis. The authors
reported good overall results of the combined procedure,
without any stroke related to the nonoperated-on carotid
artery, thus challenging the assumption that carotid disease
was an important cause of stroke during cardiac surgery.
However, this retrospective study included among the oonoperated-on group a wide range of carotid stenoses of
0% to 99%. When considering the 32 patients in this study
ith asymptomatic carotid stenoses 70%, who were con-
idered for CEA, the incidence of postoperative stroke on
he nonoperated-on site was 2.7%, which is not negligible.
f only a 30-day period had been used, the present study
ould not have reached a significant end point.
However, our main purpose was to study the potential
ffect of delayed CEA, considering that the course of
ABG may exceed 30 postoperative days, which then
orces the delayed CEA. We emphasize that the fate of
atients with a significant—but untreated—carotid steno-
is 30-day time limit has seldom been considered in the
urrent meta-analyses. The results of this study, with a
0-day surveillance period, significantly support the value
f CEA, before or combined with CABG, as a better
revention of stroke, compared with delayed CEA after
ABG.
Apart from carotid stenosis, the occurrence of atrial
brillation has also been related to stroke after CABG in
.6% to 36.5% of patients.24,25 In this randomized trial, the
ercentage of patients with atrial fibrillation was compara-
le in both groups, and none of the strokes occurred in
atients with postoperative atrial fibrillation. Atheromatous
mbolization from a diseased ascending aorta or aortic arch
t the time of aortic manipulation or cannulation during
ABG may also be responsible for postoperative stroke in
atients after CABG.18,26,27 Out analyses of the literature
ound that atherosclerosis of the ascending aorta and aortic
rch was rarely systematically investigated in patients sched-
led for CABG. In our series, however, all patients with
ignificant disease of the ascending aorta or the aortic arch
ere excluded to avoid a confounding factor in relation to
mbolic strokes due to aortic atherosclerosis, and this prob-
bly limits the external applicability of this study.
Finally, multivariate analysis in this study showed that
he duration of CPB was an additional risk factor for
ostoperative stroke and death, despite an overall differ-
nce in CPB duration between the two groups of only 5
inutes. Aside from the statistical result, we do not believe
hat a difference of 5 minutes is clinically relevant. None-
heless, among other factors, the correlation between the
ercentage of carotid artery stenosis and the reduction of
erebral perfusion during CPB is known.28 Duration of
PB, as a marker of depressed cardiac function and overall
educed cerebral perfusion, may be a predictor of a poorer
urgical outcome, particularly in case of an exceedingly
ong CPB time. This finding underscores the usefulness of
rior or combined CEA in the prevention of stroke, espe-
ially whenever lengthy CPB is anticipated during CABG.
n this study, we observed a 5% stroke rate during the first
0 days after CABG, whereas the predicted 5-year ipsilat-
ral stroke rate in patients with an asymptomatic carotid
tenosis is 11%. We have no sound explanation for this
nding but speculate that symptomatic coronary lesions are
marker of severe atheromatous disease and explain the risk
f asymptomatic carotid artery stenosis in this setting.
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October 2011998 Illuminati et alCONCLUSIONS
Our study has shown that in patients who are candi-
dates for nonurgent CABG who have unilateral severe and
asymptomatic carotid artery stenosis, prophylactic or syn-
chronous CEA could offer a better protection from isch-
emic stroke than delayed CEA. These results underline the
importance of a systematic search for significant carotid
stenosis in all patients who are candidates for CABG.
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Dr Richard Cambria (Boston, Mass). Congratulations on a
great study. And as Rob mentioned, all of the studies over the pastDr Ricotta, in back of me, has been pleading for a randomized
tudy. My own feeling is that it’s such a pleasure to comment on
his study because it reinforces or is consistent with the position
hat we’ve taken on this problem really for the past 30 years. We’ve
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Volume 54, Number 4 Illuminati et al 999published a couple of large series of combined carotid and CABG
operations. And fundamentally, our posture has been that if a
patient has a carotid stenosis that you would otherwise fix if they
walked into the office and they happened to be in need of a
coronary bypass, we fix the lesions simultaneously.
So I think that your data are very important, most important in
that it shows that patients with a critical carotid stenosis who come
through a CABG are at risk in that postoperative period as they
recover, as they are prothrombotic and so forth, and I was very
interested to see that all of the strokes occurred ipsilateral to the
carotid lesion but not as a complication of a delayed carotid
endarterectomy. So I think that this is a very important study. I
would encourage you to get it right into the Journal of Vascular
Surgery because I am sure it will have great appeal for publication.
And I have just one question: in your Group A, how did you
decide which patients got a promontory carotid endarterectomy
versus a combined procedure?
Dr Giulio Illuminati. The decision was left to the cardiac
surgeon’s choice. There are cardiac surgeons in our group who
prefer the carotid endarterectomy to be done first; others agree
that it be done simultaneously.
Dr Cambria. And I think it’s important and I’m going to take
from your answer that vascular surgeons performed all the carotid
operations, because I have a strong feeling that some of the poor
results in the literature reported with this operation are a function
of the fact that the cardiac surgeon did both of the operations.
Dr Illuminati. In this series all carotid endarterectomies were
performed by vascular surgeons.
Dr John J. Ricotta (Washington, DC). That was a very nicely
presented study and I congratulate you. You’ve been able to do
something that, as Dr Cambria said, only Norm Hertzer has been
able to do before.
I think it’s important to make a couple of points. You have
excellent results, better than most of the results in the literature,
and I think that’s because of your patient selection; no aortic
atheroma, no emergency coronary bypass, no complicated cardiac
procedures. And that was a good thing for you to do because it
allowed you to focus on the exact issue of the role of the carotid.
I’d like you just to answer two questions, because they’re
going to come up from people who do not believe that this is
indicated. One is, were there any patients who – you had a very
small group of precarotid followed by CABG, or pre-endarterec-
tomy thenCABG – but were there any patients in who you planned
to do a staged procedure in whom you did not do the staged
procedure because of a complication following their carotid end-
arterectomy? I think it needs to be clear whether there were any
patients that you planned to randomize that were excluded.Dr Illuminati. No, there were not. The 15 patients who
underwent carotid endarterectomy prior to coronary artery bypass
c
crafting had an uneventful postoperative course and were operated
f coronary artery bypass grafting with a week delay on the average.
Dr Ricotta. The second question is the severity of the carotid
tenosis. I understand that you looked at 70% and higher. Do you
ave any idea how many of these patients had truly very severe
arotid stenosis? Because, again, if you operate on patients with
oderate carotid stenosis, as have a number of other studies,
ou’re not going to get a benefit. So, I think it’s very important for
ou in themanuscript to try to outline the severe stenosis. You have
very high postoperative stroke rate. Other people have not seen
hat. I think it’s because of the severity of the stenosis in your
atients.
Dr Illuminati. About 80% of the patients had a stenosis of the
arotid artery which was over 80%. One of the patients who
resented with a late stroke actually thrombosed his previously
everely stenotic carotid artery.
Dr Ricotta.Again, I would put that in themanuscript because
think they’re very important points in patient selection.
Dr Munier M. Nazzal (Toledo, Ohio). I have three small
uestions. The first one is did you have any recurrent stenosis,
symptomatic stenosis, or they were primary?
Dr Illuminati. No, they were all primary stenoses. Redo
arotid endarterectomies have been excluded from this study.
Dr Nazzal. And the other thing is any of those patients who
re asymptomatic had any stroke before 6 months, so what’s your
efinition of asymptomatic?
Dr Illuminati. A carotid artery stenosis is defined asymptom-
tic in a patient who has not, in his global history, any evidence of
ither ischemic attack or fixed stroke.
Dr Nazzal. And from this study, how do you extrapolate on
atients who have severe asymptomatic bilateral carotid stenosis?
Dr Illuminati. They were studied systematically with preop-
rative duplex ultrasound. However, for the purposes of this study,
ilateral, severe carotid stenoses, were excluded.
Dr Peter F. Lawrence (Los Angeles, Calif). A publication 10
o 15 years ago looked at discharge diagnoses from our National
npatient Survey and showed that patients who had a CPT code for
arotid endarterectomy and a coronary artery bypass as a simulta-
eous procedure had nearly a 25% incidence of stroke. That
eemed to be the real world practice at that time. Do you think that
he much better results presented here today will be translated to
he everyday practice of carotid surgery?
Dr Illuminati. The poor results of this survey are probably
artially related to the fact that patients were not stratified for their
isk. Such survey included also patients undergoing urgent coro-
ary artery revascularization. We did not randomize such patients
n this study. In addition, for patients referred to high volume
enters with experience in carotid surgery, results tend to be better
ompared to those of the general community. This is a case for
entralization of practice.
